Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral
該当なし
完了
NCT05574699
| 対象疾患 | Chronic Disease, Diabetes Mellitus, Hypertension, Congestive Heart Failure |
|---|
| 相 | 該当なし |
|---|
| スポンサー | Johns Hopkins University |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 251 名 |
|---|
| 介入(薬剤) | Social Risk Score and CDS Tool, Standard of Care |
|---|
| 開始日 | 2023年4月30日 |
|---|
| 完了日 | 2025年5月27日 |
|---|
| 結果公開日 | 2026年7月15日 |
|---|
概要
The overarching goal of this project is to leverage health information technology (HIT) to integrate available digital information on social needs to improve care for racial and ethnic minorities and socially disadvantaged populations with chronic diseases. In the previous phases of this project the investigators developed a social risk score to identify social needs among medically under-served patients with special emphasis on application among African American patients with low income and chronic diseases who face social determinants, risk factors, and needs (SDRN) challenges. The investigators also developed a clinical decision support (CDS) tool to present the social risk score to clinical providers and sought feedback from different users on the face and content validity of the CDS tool. In the current project the investigators will run a randomized clinical trial (RCT) study to pilot test the new risk score and CDS tool in selected primary care clinics at Johns Hopkins Health System (JHHS) and in collaboration with selected community-based organizations (CBOs). This system will help identify, manage, and refer patients with both high levels of disease burden and modifiable S
Number of Emergency Department Events
12 and 24 months follow-up · events
| Intervention Group - Without Screening | 0.93 ± 1.53 events |
|---|
| Intervention Group - With Screening | 2.77 ± 4.56 events |
|---|
| Control Group - Without Screening | 1.85 ± 6.4 events |
|---|
| Control Group - With Screening | 1.77 ± 2.09 events |
|---|
| Intervention Group - Without Screening | 1.09 ± 2.41 events |
|---|
| Intervention Group - With Screening | 3.28 ± 6.69 events |
|---|
| p-value | <.0001 |
| Mean Ratio | 1.35 (95% CI 1.17–1.5) |
BENITIONS で見る
ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。